Previous Article | Next Article ![]()
Infection and Immunity, March 2001, p. 1409-1419, Vol. 69, No. 3
Department of Medical Microbiology and
Immunology, The Texas A&M University System Health Science Center,
College Station, Texas 77843-1114
Received 19 September 2000/Returned for modification 26 October
2000/Accepted 4 December 2000
We have previously described the expression cloning of nine
Borrelia burgdorferi antigens, using rabbit serum enriched
for antibodies specific for infection-associated antigens, and
determined that seven of these antigens were associated with infectious
B. burgdorferi strain B31. One of these
infection-associated antigens encoded a 451-amino-acid putative
lipoprotein containing 21 consecutive and invariant 9-amino-acid repeat
sequences near the amino terminus that we have designated VraA for
virulent strain-associated repetitive antigen A. The vraA
locus (designated BBI16 by The Institute for Genomic Research) maps to
one of the 28-kb linear plasmids (designated lp28-4) that is not
present in noninfectious strain B31 isolates. Subsequent PCR analysis
of clonal isolates of B. burgdorferi B31 from infected
mouse skin revealed a clone that lacked only lp28-4. Southern blot and
Western blot analyses indicated that the lp28-4 and VraA proteins,
respectively, were missing from this clone. We have also determined
that VraA is a surface-exposed protein based on protease accessibility
assays of intact whole cells. Furthermore, vraA expression
is modestly derepressed when cells are grown at 37°C relative to
cells grown at 32°C, suggesting that VraA is, in part, a
temperature-inducible antigen. Homologues cross-reactive to B. burgdorferi B31 VraA, most with different molecular masses, were
identified in several B. burgdorferi sensu lato isolates,
including B. andersonii, suggesting that the immunogenic epitope(s) present in strain B31 VraA is conserved between
Borrelia spp. In protection studies, only 8.3% of mice (1 of 12) immunized with full-length recombinant VraA fused to glutathione
S-transferase (GST) were susceptible to infectious
challenge with 102 B. burgdorferi strain B31,
whereas naive mice or mice immunized with GST alone were infected 40%
or 63 to 67% (depending on tissues assayed) of the time, respectively.
As such, the partial protection elicited by VraA immunization provides
an additional testable vaccine candidate to help protect against Lyme borreliosis.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.3.1409-1419.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
VraA (BBI16) Protein of Borrelia burgdorferi Is a
Surface-Exposed Antigen with a Repetitive Motif That Confers Partial
Protection against Experimental Lyme Borreliosis
*
Corresponding author. Mailing address: 407 Reynolds
Medical Bldg., Department of Medical Microbiology and Immunology, The Texas A&M University System Health Science Center, College Station, TX
77843-1114. Phone: (979) 845-1376. Fax: (979) 845-3479. E-mail: jskare{at}tamu.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|